CMS: Share Buy-Back Program - 3rd Interim Announcement

CompuGroup Medical SE: Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052
CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program – 3rd Interim Announcement
In the period from April 08, 2024 until and including April 12, 2024, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 96,177 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on March 26, 2024.
The aggregate number of shares bought back each day during the period from April 08, 2024 until and including April 12, 2024 as well as the daily volume-weighted average prices for such buy-backs are as follows:
 

Date	Aggregate volume (number of no-par value shares)	Volume-weighted average price (in EUR, excluding ancillary costs and charges)
April 08, 2024	16,067	30.0105
April 09, 2024	15,740	30.5566
April 10, 2024	31,389	30.7069
April 11, 2024	15,481	30.5986
April 12, 2024	17,500	30.7274
Total:	96,177	30.5523

The aggregate number of shares bought back within the share buy-back program in the period from March 26, 2024 until and including April 12, 2024 amounts to 273,996 shares.
Detailed information about the transactions are published on the company‘s website under https://www.cgm.com/corp_en/company/ir-en/share.html .
The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading).

Koblenz, April 15, 2024

CompuGroup Medical SE & Co. KGaA
The general partner